Summit Financial Group’s Novartis NVS Stock Holding History

Summit Financial Group’s Portfolio NVS Stock Details NVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	$353K	Hold	3,654	–	–	0.13%	141
2023 Q4	$369K	Hold	3,654	–	–	0.14%	139
2023 Q3	$372K	Sell	3,654 -40	-1%	-$4.06K	0.16%	134
2023 Q2	$373K	Hold	3,694	–	–	0.15%	139
2023 Q1	$340K	Hold	3,694	–	–	0.13%	144
2022 Q4	$335K	Hold	3,694	–	–	0.13%	150
2022 Q3	$281K	Hold	3,694	–	–	0.12%	157
2022 Q2	$312K	Hold	3,694	–	–	0.12%	154
2022 Q1	$324K	Sell	3,694 -75	-2%	-$6.49K	0.11%	158
2021 Q4	$330K	Hold	3,769	–	–	0.11%	164
2021 Q3	$308K	Hold	3,769	–	–	0.11%	170
2021 Q2	$344K	Hold	3,769	–	–	0.13%	149
2021 Q1	$322K	Sell	3,769 -8	-0.2%	-$718	0.13%	138
2020 Q4	$357K	Hold	3,777	–	–	0.16%	115
2020 Q3	$328K	Sell	3,777 -49	-1%	-$4.25K	0.16%	110
2020 Q2	$334K	Hold	3,826	–	–	0.17%	105
2020 Q1	$315K	Hold	3,826	–	–	0.19%	99
2019 Q4	$362K	Hold	3,826	–	–	0.17%	104
2019 Q3	$332K	Sell	3,826 -600	-14%	-$53.9K	0.17%	109
2019 Q2	$404K	Sell	4,426 -513	-10%	-$43.4K	0.18%	110
2019 Q1	$426K	Hold	4,939	–	–	0.33%	78
2018 Q4	$380K	Hold	4,939	–	–	0.32%	79
2018 Q3	$381K	Hold	4,939	–	–	0.28%	81
2018 Q2	$334K	Hold	4,939	–	–	0.26%	89
2018 Q1	$358K	Buy	+4,939	New	+$376K	0.28%	89

Other funds holding NVS

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Summit Financial Group's NVS Position: Q1 2024 in Review

Summit Financial Group held its Novartis (NVS) position steady in Q1 2024 at 3,654 shares worth $353K. The position accounts for 0.13% of the portfolio, ranked #141.

Summit Financial Group first reported a position in NVS in Q1 2018 and has held it in 25 quarters since. The position peaked at $426K in Q1 2019. 1,253 funds tracked by Wall St. Rank hold NVS as of Q1 2024.

Summit Financial Group held 3,654 shares of Novartis worth $353K as of Q1 2024.
Summit Financial Group left its Novartis share count unchanged in Q1 2024.
Novartis made up 0.13% of Summit Financial Group's portfolio in Q1 2024, its #141 holding.
Summit Financial Group first reported a position in Novartis in Q1 2018 and has held it in 25 quarters since.
Summit Financial Group's Novartis position peaked at $426K in Q1 2019.
1,253 funds tracked by Wall St. Rank held Novartis as of Q1 2024.

Based on Summit Financial Group's 13F filing for Q1 2024, filed 5 Apr 2024.